Carbaglu product information

Introduction

This is a summary of the European Public Assessment Report (EPAR) for Carbaglu. It explains how the Committee for Medicinal Products for Human Use (CHMP) evaluated the drug to arrive at a positive opinion for granting marketing authorization and makes recommendations on the conditions of use for Carbaglu.

View product information

Don't miss our upcoming events